Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
Open Access
- 1 October 2004
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 17 (4), 770-782
- https://doi.org/10.1128/cmr.17.4.770-782.2004
Abstract
SUMMARY: Pneumocystis infection in humans was originally described in 1942. The organism was initially thought to be a protozoan, but more recent data suggest that it is more closely related to the fungi. Patients with cellular immune deficiencies are at risk for the development of symptomatic Pneumocystis infection. Populations at risk also include patients with hematologic and nonhematologic malignancies, hematopoietic stem cell transplant recipients, solid-organ recipients, and patients receiving immunosuppressive therapies for connective tissue disorders and vasculitides. Trimethoprim-sulfamethoxazole is the agent of choice for prophylaxis against Pneumocystis unless a clear contraindication is identified. Other options include pentamidine, dapsone, dapsone-pyrimethamine, and atovaquone. The risk for PCP varies based on individual immune defects, regional differences, and immunosuppressive regimens. Prophylactic strategies must be linked to an ongoing assessment of the patient's risk for disease.Keywords
This publication has 158 references indexed in Scilit:
- A Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Diagnosis ofPneumocystis cariniiPneumonia: Improved Detection in Sputum with Use of Monoclonal AntibodiesNew England Journal of Medicine, 1988
- Successful Intermittent Chemoprophylaxis forPneumocystis cariniiPneumonitisNew England Journal of Medicine, 1987
- Prevalence of Pneumocystis carinii pneumonitis in severe combined immunodeficiencyThe Journal of Pediatrics, 1981
- Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumoniaThe Journal of Pediatrics, 1978
- Successful Chemoprophylaxis forPneumocystis cariniiPneumonitisNew England Journal of Medicine, 1977
- Pneumocystis carinii pneumonitis in children with malignanciesThe Journal of Pediatrics, 1973
- Recurrent Pneumocystis carinii pneumonia following apparent recoveryThe Journal of Pediatrics, 1971